🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

15 recruiting trials

for Cone-Rod Degeneration

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) NCT06445322n/a9 sites📍 San Francisco📍 Gainesville📍 Baltimore Ascidian Therapeutics, Inc · Tests: Prescreening Assessments Inherited Retinal Degenerative Disease Registry NCT02435940n/a1 site📍 Columbia Foundation Fighting Blindness Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease NCT04289571Phase 12 sites📍 Bethesda📍 Sydney National Eye Institute (NEI) · Tests: VR Mobility Tool EyeConic: Qualification for Cone-Optogenetics NCT05294978n/a9 sites📍 San Francisco📍 Miami📍 Pittsburgh Institute of Molecular and Clinical Ophthalmology Basel · Tests: Optical coherence tomography (OCT) Adaptive Optics Imaging of Outer Retinal Diseases NCT05355415n/a2 sites📍 Bethesda📍 Silver Spring Food and Drug Administration (FDA) · Tests: Adaptive optics imaging Angiogenic Biomarkers in Juvenile Idiopathic Arthritis NCT05534347n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Blood sample, Joint puncture A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) NCT06789445Phase 1, Phase 25 sites📍 Los Angeles📍 Miami📍 Philadelphia BlueRock Therapeutics · Tests: OpCT-001, OpCT-001 Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment NCT07341763NA1 site📍 Waterloo University of Waterloo · Tests: Active hf-tRNS., Placebo/sham hf-tRNS Stem Cell Ophthalmology Treatment Study II NCT03011541NA4 sites📍 Westport📍 Coral Springs📍 Vienna MD Stem Cells · Tests: Arm 1 Rod and Cone Mediated Function in Retinal Disease NCT02617966n/a1 site📍 Bethesda National Eye Institute (NEI) Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) NCT06467344Phase 1, Phase 211 sites📍 San Francisco📍 Gainesville📍 Miami Ascidian Therapeutics, Inc · Tests: ACDN-01 Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance NCT07548944n/a1 site📍 Frankfurt am Main Okuvision GmbH · Tests: Transcorneal Electrical Stimulation using the OkuStim System Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy NCT07807111Phase 1, Phase 23 sites📍 Ghent📍 Paris📍 Dublin SparingVision · Tests: SPVN20 (high dose), SPVN20 (medium dose), SPVN20 (low dose) Natural History Study of Advanced RCD NCT07854899NA3 sites📍 Ghent📍 Paris📍 Dublin SparingVision · Tests: Eye examinations, Questionnaire Evaluating the Safety and Tolerability of Orally Administered DF-003 in ROSAH Syndrome Patients NCT06395285Phase 15 sites📍 Bethesda📍 Durham📍 Salt Lake City Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Fa… · Tests: DF-003
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy